Combination of metformin and thiazolidindiones restore insulin signalling in insulin-resistant cultured myotubes

This publication has 25 references indexed in Scilit:

• Pioglitazone Ameliorates Tumor Necrosis Factor-α–Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator–Activated Receptor-γ
  Diabetes, 2001
• Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus
  JAMA, 2000
• Hepatic Failure in a Patient Taking Rosiglitazone
  Annals of Internal Medicine, 2000
• Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes
  New England Journal of Medicine, 1999
• Insulin Receptor Substrate-2 Is Not Necessary for Insulin- and Exercise-stimulated Glucose Transport in Skeletal Muscle
  Journal of Biological Chemistry, 1999
• Actions of novel antidiabetic thiazolidinedione, T‐174, in animal models of non‐insulin‐dependent diabetes mellitus (NIDDM) and in cultured muscle cells
  British Journal of Pharmacology, 1998
• Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
  New England Journal of Medicine, 1998
• Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents
  Metabolism, 1995
• Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
  Journal of Clinical Investigation, 1995
• The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization
  Diabetes, 1981